# potassium chloride sustained-release

### notes
+ prescription under medical supervision

### therapeutic action
+ potassium supplement

### indications
+ hypokalaemia induced by :
    - thiazide diuretics (e.g. hydrochlorothiazide)
    - loop diuretics (e.g. furosemide)

### presentation
+ 600 mg potassium chloride sustained-release tablet (8 mmol of k+)

### dosage
+ adult: 15 to 25 mmol/day = 2 to 3 tablets/day in 2 to 3 divided doses
+ do not exceed indicated doses if potassium serum levels cannot be measured.

### duration
+ according to clinical response and duration of diuretic treatment

### contra-indications, adverse effects, precautions
+ administer with caution and reduce dosage in elderly patients and in patients with renal impairment (risk of hyperkalaemia).
+ do not combine with spironolactone and angiotensin-converting-enzyme inhibitors (e.g. enalapril).
+ may cause: hyperkalaemia, gastroduodenal ulcerations, diarrhoea, nausea and vomiting.
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contra-indication

### remarks
+ take with or at the end meals in order to reduce the risk of gastrointestinal ulcerations.
+ hypokalaemia is defined as a serum potassium concentration below 3.5 mmol/l.
+ if tablets are not available, a lack of potassium may be corrected by a diet rich in dates, bananas, mangos, oranges, tomatoes, etc.
+ storage: below 25Â°c
